Mifepristone-misoprostol - change to listing - EML

被引：0
|
作者：
机构：
来源：
SELECTION AND USE OF ESSENTIAL MEDICINES: REPORT OF THE WHO EXPERT COMMITTEE ON SELECTION AND USE OF ESSENTIAL MEDICINES, 2019 (INCLUDING THE 21ST WHO MODEL LIST OF ESSENTIAL MEDICINES AND THE 7TH WHO MODEL LIST OF ESSENTIAL MEDICINES FOR CHILDREN) | 2019年 / 1021卷
关键词：
MEDICAL ABORTION; TERMINATION; PROVISION; PROVIDERS; SAFETY; CARE;
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
下载
收藏
页码：422 / 428
页数：7
相关论文
共 50 条
  • [31] Efficacy and acceptability of a mifepristone-misoprostol combined regimen for early induced abortion among women in Mexico City
    Pena, Melanie
    Dzuba, Ilana G.
    Sanhueza Smith, Patricio
    Arellano Mendoza, Luis Jorge
    Bousieguez, Manuel
    Garcia Martinez, Maria Laura
    Rios Polanco, Ranulfo
    Flores Villalon, Antonio Eduardo
    Winikoff, Beverly
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2014, 127 (01) : 82 - 85
  • [32] Acceptability and side effects of early abortion with mifepristone-misoprostol compared to vacuum aspiration in China, Cuba and India
    不详
    REPRODUCTIVE HEALTH MATTERS, 2000, 8 (15) : 185 - 185
  • [33] Acceptability and feasibility of early pregnancy termination by mifepristone-misoprostol - Results of a large multicenter trial in the United States
    Winikoff, B
    Ellertson, C
    Elul, B
    Sivin, I
    ARCHIVES OF FAMILY MEDICINE, 1998, 7 (04) : 360 - 366
  • [34] Summary for Patients: Short-Term Adverse Outcomes After Mifepristone-Misoprostol Versus Procedural Induced Abortion
    Liu, N.
    Ray, J. G.
    ANNALS OF INTERNAL MEDICINE, 2023, 176 (02) : I14 - I14
  • [35] Side effects of mifepristone-misoprostol abortion versus surgical abortion - Data from a trial in China, Cuba, and India
    Elul, B
    Ellertson, C
    Winikoff, B
    Coyaji, K
    CONTRACEPTION, 1999, 59 (02) : 107 - 114
  • [36] Cost of goods sold analysis and recommendations to reduce costs of co-packaged mifepristone-misoprostol for medical abortion
    Chinery, Lester
    Allaouidine, Chadia
    Tomazzini, Alessandra
    Larson, Melanie
    Gulmezoglu, A. Metin
    REPRODUCTIVE HEALTH, 2020, 17 (01)
  • [37] 24-Hour Compared With 12-Hour Mifepristone-Misoprostol Interval for Second-Trimester Abortion
    Meyer, Raanan
    Toussia-Cohen, Shlomi
    Shats, Maya
    Segal, Omri
    Mohr-Sasson, Aya
    Peretz-Bookstein, Shiran
    Amitai-Komem, Daphna
    Sindel, Ofra
    Levin, Gabriel
    Mashiach, Roy
    Blumenthal, Paul D.
    OBSTETRICS AND GYNECOLOGY, 2024, 144 (01): : 60 - 67
  • [38] MISOPROSTOL PLUS MIFEPRISTONE
    FONSECA, W
    MISAGO, C
    KANJI, N
    LANCET, 1991, 338 (8782-3): : 1594 - 1594
  • [39] MISOPROSTOL, MIFEPRISTONE, AND ABORTION
    BAIRD, DT
    NORMAN, JE
    THONG, KJ
    GLASIER, AF
    LANCET, 1992, 339 (8788): : 313 - 313
  • [40] Safety, efficacy, and acceptability of medical abortion in China, Cuba, and India: A comparative trial of mifepristone-misoprostol versus surgical abortion
    Winikoff, B
    Sivin, I
    Coyaji, KJ
    Cabezas, E
    Xiao, BL
    Gu, SJ
    Du, MK
    Krishna, UR
    Eschen, A
    Ellertson, C
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1997, 176 (02) : 431 - 437
12345